ORANGE COUNTY, Calif. (June 16, 2024) – Beckman
Coulter, Inc., has entered into a strategic alliance with
CaridianBCT, under the terms of which Beckman Coulter will market
CaridianBCT cell therapy products in specific, targeted
markets.
CaridianBCT and Beckman Coulter will launch CaridianBCT's Quantum
Cell Expansion System, a closed system that automates the cell
expansion process, along with marketing CaridianBCT’s COBE*
2991 Cell Processor, a system that washes and concentrates cell
populations, and the Elutra* Cell Separation System, which purifies
cell populations via elutriation.
Adding the Quantum, Elutra and COBE 2991 systems to the Beckman
Coulter line of products for cell sorting, cellular analysis and
characterization will enable the company to provide pharmaceutical
companies, research institutes and clinical trial organizations
with a full line of cellular discovery systems.
"Beckman Coulter is pleased to have CaridianBCT as a strategic
partner and values their expertise in cell processing and sterile,
closed systems," said Cynthia Collins, group vice president of
Cellular Analysis at Beckman Coulter. "We are committed to
being the leader in cell therapy tools, and with the addition of
these three products to our portfolio of cell sorters, flow
cytometers and reagents, we now provide an even wider selection of
tools for cell therapy."
"CaridianBCT has been enabling cell therapy applications around the
world for over 30 years with proven systems that collect, separate,
wash and concentrate human cells," said Tom Jordan, senior vice
president of Therapeutic Systems at CaridianBCT. "We are
confident that Beckman Coulter’s broad market reach and
product portfolio, coupled with our innovative systems, will
further advance the field of cell therapy."
CaridianBCT will retain the distribution rights to these cell
therapy products in other market segments including commercial cell
therapy developers, cell therapy contract manufacturing
organizations, the veterinary market, and the cord-blood bank and
blood bank markets.
About Beckman Coulter, Inc.
Beckman Coulter, Inc., based in Orange County, California,
develops, manufactures and markets products that simplify, automate
and innovate complex biomedical tests. More than 200,000
Beckman Coulter systems operate in laboratories around the world,
supplying critical information for improving patient health and
reducing the cost of care. Recurring revenue, consisting of
consumable supplies (including reagent test kits), service and
operating-type lease payments, represent about 80 percent of the
company's 2009 revenue of $3.3 billion. For more information, visit
www.beckmancoulter.com.
*Elutra and COBE are registered trademarks of CaridianBCT.
Beckman Coulter and the stylized logo are registered trademarks of
Beckman Coulter, Inc.
SOURCE